on no account Sublocade Approval History FDA approved: Yes (First approved November 30th, 2017) Brand name: Sublocade Generic name: buprenorphine Dosage form: Sustained-Release Injection Previous name: RBP-6000 Company: Indivior PLC Treatment for: Opiate Dependence Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the treatment of opioid use disorder (OUD). Development History and FDA Approval Process for Sublocade Date Article Nov 30, 2017 FDA Approves Sublocade (buprenorphine) Once-Monthly Injection for Opioid Use Disorder Oct 31, 2017 FDA Advisory Committees Recommend Approval of Indivior s RBP-6000 for the Treatment of Opioid Use Disorder May 30, 2017 Indivior Submits New Drug Application to U.S. FDA for RBP-6000 Buprenorphine Monthly Depot See also... Sublocade (buprenorphine) Consumer Information Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist. Recently Approved Admelog Admelog (insulin lispro) is a follow-on insulin product (referenced to Humalog) for the treatment... Sinuva Sinuva (mometasone furoate) is a corticosteroid-eluting sinus implant indicated for the treatment... Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... More every now and then
foundation Sublocade Approval History without boundary lines
EmoticonEmoticon